Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_assertion type Assertion NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_head.
- NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_assertion description "[Furthermore, we have shown that FGF2 can promote the expression of FGF2 and cyclooxygenase-2, and enhance proliferation of endometrial adenocarcinoma cells via the FGFR1 and ERK pathways, thereby establishing a positive feedback loop to regulate neoplastic epithelial cell function in endometrial adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_provenance.
- NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_assertion evidence source_evidence_literature NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_provenance.
- NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_assertion SIO_000772 17478553 NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_provenance.
- NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_assertion wasDerivedFrom befree-20150227 NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_provenance.
- NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_assertion wasGeneratedBy ECO_0000203 NP376362.RAdFHT007Qf7V0Y5_oO7HGCssdePdTFgKM4Mfw_Go-1h4130_provenance.